Article
$4.75 million grant to fund stem-cell work
The Lincy Foundation has given the first installment of a 4-year, $4.75 million grant to the Oregon Retinal Degeneration Center at Oregon Health & Science (OHSU) Casey Eye Institute.
Portland, OR-The Lincy Foundation has given the first installment of a 4-year, $4.75 million grant to the Oregon Retinal Degeneration Center at Oregon Health & Science (OHSU) Casey Eye Institute.
The grant will be used to develop stem-cell therapies to treat retinal degeneration, in particular age-related macular degeneration.
The grant will allow OHSU to be one of the only institutes in the country to test stem-cell therapies to prevent blindness from degenerative eye diseases. The grant will fund research from the initial stages through animal model testing and on to a phase I clinical trial to test the safety of the therapies in humans.
The Beverly Hills, CA-based Lincy Foundation is the primary philanthropic vehicle of billionaire investor Kirk Kerkorian.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
